<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01883856</url>
  </required_header>
  <id_info>
    <org_study_id>16051</org_study_id>
    <nct_id>NCT01883856</nct_id>
  </id_info>
  <brief_title>Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves</brief_title>
  <official_title>Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Netland, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New World Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate and compare the clinical outcomes after implantation&#xD;
      of the porous plate (polyethylene) (Model M4) Ahmed Glaucoma Valve with the silicone plate&#xD;
      Ahmed Glaucoma Valve (Model FP7) in participants with refractory glaucoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate and compare the clinical outcomes after implantation&#xD;
      of the porous plate (polyethylene) (Model M4) Ahmed Glaucoma Valve with the silicone plate&#xD;
      Ahmed Glaucoma Valve (Model FP7) in participants with refractory glaucoma. Participation will&#xD;
      last for 12 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">August 27, 2018</completion_date>
  <primary_completion_date type="Actual">September 10, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Intraocular Pressure</measure>
    <time_frame>12 months</time_frame>
    <description>The primary endpoint is the mean intraocular pressure in the porous plate group as compared to the silicone plate group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anti-Glaucoma Medications</measure>
    <time_frame>12 months</time_frame>
    <description>The mean number of anti-glaucoma medications in the porous plate group as compared to the silicone plate group at 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Success</measure>
    <time_frame>12 months</time_frame>
    <description>Surgical success in the porous plate group as compared to the silicone plate group at 12 months. Surgical success was defined as intraocular pressure of ≤5 mmHg or ≥21 mmHg (with or without glaucoma medications), with no loss of light perception, and no additional glaucoma procedures.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Silicone Plate Ahmed Glaucoma Valve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Silicone plate Ahmed Glaucoma Valve</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Porous Plate Ahmed Glaucoma Valve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Porous Plate Ahmed Glaucoma Valve</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Silicone plate Ahmed Glaucoma Valve (Model FP7)</intervention_name>
    <description>This intervention is conducted as a surgical intervention.</description>
    <arm_group_label>Silicone Plate Ahmed Glaucoma Valve</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Porous Plate Ahmed Glaucoma Valve (Model M4)</intervention_name>
    <description>This intervention is conducted as a surgical intervention.</description>
    <arm_group_label>Porous Plate Ahmed Glaucoma Valve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female of any race ≥ 18 years and ≤ 80 years of age.&#xD;
&#xD;
          -  Diagnosis of intractable glaucoma in the study eye, with the exception of silicone oil&#xD;
             endotamponade induced glaucoma, which has not responded to conventional medical and&#xD;
             surgical therapy.&#xD;
&#xD;
          -  Elevated intraocular pressure &gt; 21 mmHg in the study eye. Two consecutive measurements&#xD;
             using Goldmann Applanation Tonometry will be obtained and the mean of those two&#xD;
             measurements will be considered the subject's baseline intraocular pressure.&#xD;
&#xD;
          -  Subject is a candidate for surgery in the study eye with a glaucoma drainage device.&#xD;
&#xD;
          -  Subject is willing and able to sign the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of silicone oil endotamponade induced glaucoma in the study eye.&#xD;
&#xD;
          -  History of prior drainage implant surgery in the study eye.&#xD;
&#xD;
          -  History of cyclophotocoagulation of the study eye.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Prisoner.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter A Netland, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/32765127/</url>
    <description>Study results indexed on Pub Med</description>
  </link>
  <results_reference>
    <citation>Roa TM, Netland PA, Costa VP, Sarkisian SR Jr, Al-Aswad LA, Moster MR, Ahmed IIK. Comparison of Silicone- and Porous-Plate Ahmed Glaucoma Valves. Med Devices (Auckl). 2020 Jul 16;13:213-221. doi: 10.2147/MDER.S258498. eCollection 2020.</citation>
    <PMID>32765127</PMID>
  </results_reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 18, 2013</study_first_submitted>
  <study_first_submitted_qc>June 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2013</study_first_posted>
  <results_first_submitted>August 25, 2020</results_first_submitted>
  <results_first_submitted_qc>August 25, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 18, 2020</results_first_posted>
  <last_update_submitted>September 21, 2020</last_update_submitted>
  <last_update_submitted_qc>September 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Peter Netland, MD</investigator_full_name>
    <investigator_title>Chair, Department of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Refractory Glaucoma</keyword>
  <keyword>Intractable Glaucoma</keyword>
  <keyword>Primary Open Angle Glaucoma</keyword>
  <keyword>Neovascular Glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Described in study results - https://pubmed.ncbi.nlm.nih.gov/32765127/</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 25, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/56/NCT01883856/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Silicone Plate Ahmed Glaucoma Valve</title>
          <description>Silicone plate Ahmed Glaucoma Valve&#xD;
Silicone plate Ahmed Glaucoma Valve (Model FP7): This intervention is conducted as a surgical intervention.</description>
        </group>
        <group group_id="P2">
          <title>Porous Plate Ahmed Glaucoma Valve</title>
          <description>Porous Plate Ahmed Glaucoma Valve&#xD;
Porous Plate Ahmed Glaucoma Valve (Model M4): This intervention is conducted as a surgical intervention.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Silicone Plate Ahmed Glaucoma Valve</title>
          <description>Silicone plate Ahmed Glaucoma Valve&#xD;
Silicone plate Ahmed Glaucoma Valve (Model FP7): This intervention is conducted as a surgical intervention.</description>
        </group>
        <group group_id="B2">
          <title>Porous Plate Ahmed Glaucoma Valve</title>
          <description>Porous Plate Ahmed Glaucoma Valve&#xD;
Porous Plate Ahmed Glaucoma Valve (Model M4): This intervention is conducted as a surgical intervention.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="26"/>
            <count group_id="B3" value="52"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.7" spread="11.2"/>
                    <measurement group_id="B2" value="67.0" spread="10.1"/>
                    <measurement group_id="B3" value="67.3" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ethnicity</title>
              <category_list>
                <category>
                  <title>African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mixed Race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-operative intraocular pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.91" spread="6.55"/>
                    <measurement group_id="B2" value="33.79" spread="10.54"/>
                    <measurement group_id="B3" value="31.85" spread="8.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Intraocular Pressure</title>
        <description>The primary endpoint is the mean intraocular pressure in the porous plate group as compared to the silicone plate group.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Silicone Plate Ahmed Glaucoma Valve</title>
            <description>Silicone plate Ahmed Glaucoma Valve&#xD;
Silicone plate Ahmed Glaucoma Valve (Model FP7): This intervention is conducted as a surgical intervention.</description>
          </group>
          <group group_id="O2">
            <title>Porous Plate Ahmed Glaucoma Valve</title>
            <description>Porous Plate Ahmed Glaucoma Valve&#xD;
Porous Plate Ahmed Glaucoma Valve (Model M4): This intervention is conducted as a surgical intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Intraocular Pressure</title>
          <description>The primary endpoint is the mean intraocular pressure in the porous plate group as compared to the silicone plate group.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.60" spread="4.69"/>
                    <measurement group_id="O2" value="17.94" spread="10.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anti-Glaucoma Medications</title>
        <description>The mean number of anti-glaucoma medications in the porous plate group as compared to the silicone plate group at 12 months.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Silicone Plate Ahmed Glaucoma Valve</title>
            <description>Silicone plate Ahmed Glaucoma Valve&#xD;
Silicone plate Ahmed Glaucoma Valve (Model FP7): This intervention is conducted as a surgical intervention.</description>
          </group>
          <group group_id="O2">
            <title>Porous Plate Ahmed Glaucoma Valve</title>
            <description>Porous Plate Ahmed Glaucoma Valve&#xD;
Porous Plate Ahmed Glaucoma Valve (Model M4): This intervention is conducted as a surgical intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Anti-Glaucoma Medications</title>
          <description>The mean number of anti-glaucoma medications in the porous plate group as compared to the silicone plate group at 12 months.</description>
          <units>glaucoma medications</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.64" spread="1.40"/>
                    <measurement group_id="O2" value="1.89" spread="1.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Surgical Success</title>
        <description>Surgical success in the porous plate group as compared to the silicone plate group at 12 months. Surgical success was defined as intraocular pressure of ≤5 mmHg or ≥21 mmHg (with or without glaucoma medications), with no loss of light perception, and no additional glaucoma procedures.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Silicone Plate Ahmed Glaucoma Valve</title>
            <description>Silicone plate Ahmed Glaucoma Valve&#xD;
Silicone plate Ahmed Glaucoma Valve (Model FP7): This intervention is conducted as a surgical intervention.</description>
          </group>
          <group group_id="O2">
            <title>Porous Plate Ahmed Glaucoma Valve</title>
            <description>Porous Plate Ahmed Glaucoma Valve&#xD;
Porous Plate Ahmed Glaucoma Valve (Model M4): This intervention is conducted as a surgical intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Surgical Success</title>
          <description>Surgical success in the porous plate group as compared to the silicone plate group at 12 months. Surgical success was defined as intraocular pressure of ≤5 mmHg or ≥21 mmHg (with or without glaucoma medications), with no loss of light perception, and no additional glaucoma procedures.</description>
          <units>surgical success</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Silicone Plate Ahmed Glaucoma Valve</title>
          <description>Silicone plate Ahmed Glaucoma Valve&#xD;
Silicone plate Ahmed Glaucoma Valve (Model FP7): This intervention is conducted as a surgical intervention.</description>
        </group>
        <group group_id="E2">
          <title>Porous Plate Ahmed Glaucoma Valve</title>
          <description>Porous Plate Ahmed Glaucoma Valve&#xD;
Porous Plate Ahmed Glaucoma Valve (Model M4): This intervention is conducted as a surgical intervention.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertensive phase</sub_title>
                <description>Hypertensive phase was defined as intraocular pressure more than 21 mmHg during the first three months postoperatively.</description>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="26"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Peter A. Netland, MD, PhD</name_or_title>
      <organization>University of Virginia</organization>
      <phone>4349821086</phone>
      <email>pan9c@virginia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

